British researchers have unveiled a database of chronic myeloid leukaemia samples in a bid to encourage research into the disease.
The database is to be freely available to researchers throughout the world in the hope of it leading to improved therapies and a cure.
Scientists at the universities of Glasgow, UK, and Melbourne, Australia, have worked together on the project, known as LEUKomics.
The database has 100 samples, a large number for research into CML.
Professor Jeff Evans, director of the Institute of Cancer Sciences at the University of Glasgow said: 'LEUKomics is a very valuable resource and could help us to reveal new underlying mechanisms that drive CML.
'It has the potential to transform CML research on a global level, as the findings can be downloaded and shared with other researchers across the world. We also hope it inspires new research ideas, and ultimately fuels a global search into finding cures for CML.'
Dr Alasdair Rankin, of the charity Bloodwise, which has backed the project, said: 'Thanks to research, most patients with CML will now live a normal life by taking a single pill. But treatment is life-long and not everyone can tolerate the side effects from their treatment, or may not respond and see their CML return.
'There remains a need to develop a permanent cure for all people with this blood cancer.'